Succinate dehydrogenase complex subunit C (SDHC) is a subunit of mitochondrial complex II (MCII), which is also known as succinate dehydrogenase (SDH) or succinate: ubiquinone oxidoreductase. Mitochondrial complex II is the smallest respiratory complex in the respiratory chain and contains four subunits. SDHC is a membrane-anchored subunit of SDH, which connects the tricarboxylic acid cycle and the electron transport chain. SDH regulates several physiological processes within cells, plays an important role in generating energy to maintain normal cell growth, and is involved in apoptosis. Currently, SDHC is generally recognized as a tumor-suppressor gene. SDHC mutations can cause oxidative damage in the body. It is closely related to the occurrence and development of cancer, neurodegenerative diseases, and aging-related diseases. Here, we review studies on the structure, biological function, related diseases of SDHC, and the mev-1 Animal Model of SDHC Mutation and its potential use as a therapeutic target of certain human diseases.
Elbehti-GreenAAuHCMascarelloJTReam-RobinsonDSchefflerIE.Characterization of the human SDHC gene encoding of the integral membrane proteins of succinate-quinone oxidoreductase in mitochondria.Gene1998;213:133–40
2.
HirawakeHTaniwakiMTamuraAKojimaSKitaK.Cytochrome b in human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of the components in liver mitochondria and chromosome assignment of the genes for the large (SDHC) and small (SDHD) subunits to 1q21 and 11q23.Cytogenet Cell Genet1997;79:132–8
3.
GebertNGebertMOeljeklausSvon der MalsburgKStroudDAKulawiakBWirthCZahediRPDolezalPWieseSSimonOSchulze-SpeckingATruscottKNSickmannARehlingPGuiardBHunteCWarscheidBvan der LaanMPfannerNWiedemannN.Dual function of Sdh3 in the respiratory chain and TIM22 protein translocase of the mitochondrial inner membrane.Molecular Cell2011;44:811–8
4.
RutterJWingeDRSchiffmanJD.Succinate dehydrogenase—assembly, regulation and role in human disease.Mitochondrion2010;10:393–401
5.
NaUYuWCoxJBrickerDKBrockmannKRutterJThummelCSWingeDR.The LYR factors SDHAF1 and SDHAF3 mediate maturation of the iron-sulfur subunit of succinate dehydrogenase.Cell Metabolism2014;20:253–66
6.
KimHJJeongMYNaUWingeDR.Flavinylation and assembly of succinate dehydrogenase are dependent on the C-terminal tail of the flavoprotein subunit.J Biol Chem2012;287:40670–9
7.
LemarieAGrimmS.Mutations in the heme b-binding residue of SDHC inhibit assembly of respiratory chain complex II in mammalian cells.Mitochondrion2009;9:254–60
8.
SchefflerIE.Molecular genetics of succinate:quinone oxidoreductase in eukaryotes.Prog Nucleic Acid Res Mol Biol1998;60:267–315
9.
JangSJavadovS.Elucidating the contribution of ETC complexes I and II to the respirasome formation in cardiac mitochondria.Sci Rep2018;8:17732
10.
SunFHuoXZhaiYWangAXuJSuDBartlamMRaoZ.Crystal structure of mitochondrial respiratory membrane protein complex II.Cell2005;121:1043–57
11.
YankovskayaVHorsefieldRTörnrothSLuna-ChavezCMiyoshiHLégerCByrneBCecchiniGIwataS.Architecture of succinate dehydrogenase and reactive oxygen species generation.Science (New York, NY)2003;299:700–4
12.
GuoJLemireBD.The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide.J Biol Chem2003;278:47629–35
13.
AndersonRFHilleRShindeSSCecchiniG.Electron transfer within complex II. Succinate:ubiquinone oxidoreductase of Escherichia coli.J Biol Chem2005;280:33331–7
14.
IshiiNFujiiMHartmanPSTsudaMYasudaKSenoo-MatsudaNYanaseSAyusawaDSuzukiK.A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.Nature1998;394:694–7
15.
SzetoSSWReinkeSNSykesBDLemireBD. Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate.J Biol Chem2007;282:27518–26
16.
TurrensJFAlexandreALehningerAL.Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.Arch Biochem Biophys1985;237:408–14
17.
D’AngioCTFinkelsteinJN.Oxygen regulation of gene expression: a study in opposites.Mol Genet Metab2000;71:371–80
18.
BauerMFHofmannSNeupertWBrunnerM.Protein translocation into mitochondria: the role of TIM complexes.Trends Cell Biol2000;10:25–31
19.
HwangMSRohlenaJDongLFNeuzilJGrimmS.Powerhouse down: complex II dissociation in the respiratory chain.Mitochondrion2014;19:20–8
20.
AlbayrakTGrimmS.A high-throughput screen for single gene activities: isolation of apoptosis inducers.Biochem Biophys Res Commun2003;304:772–6
21.
LemarieAHucLPazarentzosEMahul-MellierALGrimmS.Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction.Cell Death Differ2011;18:338–49
22.
AlbayrakTScherhammerVSchoenfeldNBraziulisEMundTBauerMKSchefflerIEGrimmS.The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction.Mol Biol Cell2003;14:3082–96
23.
ChenZZhongC.Oxidative stress in Alzheimer’s disease.Neurosci Bull2014;30:271–81
24.
KattoorAJPothineniNVKPalagiriDMehtaJL.Oxidative stress in atherosclerosis.Curr Atheroscler Rep2017;19:42
25.
MoldogazievaNTMokhosoevIMMel’nikovaTIPorozovYBTerentievAA.Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases.Oxid Med Cell Longev2019;2019:3085756
26.
MaYYWuTFLiuYPWangQLiXYDingYSongJQShiXYZhangWNZhaoMHuLYJuJWangZLYangYLZouLP.Two compound frame-shift mutations in succinate dehydrogenase gene of a Chinese boy with encephalopathy.Brain Dev2014;36:394–8
27.
ParfaitBChretienDRötigAMarsacCMunnichARustinP.Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome.Hum Genet2000;106:236–43
28.
DamianoMDiguetEMalgornCD’AurelioMGalvanLPetitFBenhaimLGuillermierMHouitteDDufourNHantrayePCanalsJMAlberchJDelzescauxTDéglonNBealMFBrouilletE.A role of mitochondrial complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin.Hum Mol Genet2013;22:3869–82
29.
OhlenbuschAEdvardsonSSkorpenJBjornstadASaadaAElpelegOGärtnerJBrockmannK.Leukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency.Orphanet J Rare Dis2012;7:69
30.
IshiiTTakanashiYSugitaKMiyazawaMYanagiharaRYasudaKOnouchiHKawabeNNakataMYamamotoYHartmanPSIshiiN.Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain.Aging Cell2017;16:39–51
31.
Van VrankenJGNaUWingeDRRutterJ.Protein-mediated assembly of succinate dehydrogenase and its cofactors.Crit Rev Biochem Mol Biol2015;50:168–80
32.
Díaz-CastroBPintadoCOGarcía-FloresPLópez-BarneoJPiruatJI.Differential impairment of catecholaminergic cell maturation and survival by genetic mitochondrial complex II dysfunction.Mol Cell Biol2012;32:3347–57
33.
ChiJXieQJiaJLiuXSunJDengYYiL.Integrated analysis and identification of novel biomarkers in Parkinson’s disease.Front Aging Neurosci2018;10:178
34.
AguiarPMSeverinoP.Biomarkers in Parkinson disease: global gene expression analysis in peripheral blood from patients with and without mutations in PARK2 and PARK8.Einstein (Sao Paulo, Brazil)2010;8:291–7
35.
YanJZhangPJiaoFWangQHeFZhangQZhangZLvZPengXCaiHTianB.Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.PLoS ONE2017;12:e0182092
36.
LongJHePShenYLiR.New evidence of mitochondria dysfunction in the female Alzheimer’s disease brain: deficiency of estrogen receptor-β.J Alzheimers Dis2012;30:545–58
37.
HattoriNTanakaMOzawaTMizunoY.Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson’s disease.Ann Neurol1991;30:563–71
38.
Jodeiri FarshbafMKiani-EsfahaniA. Succinate dehydrogenase: prospect for neurodegenerative diseases.Mitochondrion2018;42:77–83
39.
MiyazawaMIshiiTKirinashizawaMYasudaKHinoOHartmanPSIshiiN.Cell growth of the mouse SDHC mutant cells was suppressed by apoptosis throughout mitochondrial pathway.Biosci Trends2008;2:22–30
40.
SlaneBGAykin-BurnsNSmithBJKalenALGoswamiPCDomannFESpitzDR.Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability.Cancer Res2006;66:7615–20
41.
IshiiTYasudaKAkatsukaAHinoOHartmanPSIshiiN.A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis.Cancer Res2005;65:203–9
42.
SelakMAArmourSMMacKenzieEDBoulahbelHWatsonDGMansfieldKDPanYSimonMCThompsonCBGottliebE.Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.Cancer Cell2005;7:77–85
43.
BrièreJJFavierJBénitPEl GhouzziVLorenzatoARabierDDi RenzoMFGimenez-RoqueploAPRustinP.Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions.Hum Mol Genet2005;14:3263–9
44.
RuanKSongGOuyangG.Role of hypoxia in the hallmarks of human cancer.J Cell Biochem2009;107:1053–62
45.
SatohNYokoyamaCItamuraNMiyajima-NakanoYHisatomiH.Alternative splicing isoform in succinate dehydrogenase complex, subunit C causes downregulation of succinate-coenzyme Q oxidoreductase activity in mitochondria.Oncol Lett2015;9:330–4
46.
TrombettiSSessaRCatapanoRRinaldiLLo BiancoAFelicielloAIzzoPGrossoM.Exploring the leukemogenic potential of GATA-1(S), the shorter isoform of GATA-1: novel insights into mechanisms hampering respiratory chain complex II activity and limiting oxidative phosphorylation efficiency.Antioxidants (Basel, Switzerland)2021;10:1603
47.
ZhangYQianJGuCYangY.Alternative splicing and cancer: a systematic review.Signal Transduct Target Ther2021;6:78
48.
NiemannSSteinbergerDMüllerU.PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma.Neurogenetics1999;2:167–70
49.
NiemannSMüllerU.Mutations in SDHC cause autosomal dominant paraganglioma, type 3.Nat Genet2000;26:268–70
50.
WilliamsSTChatzikyriakouPCarrollPVMcGowanBMVelusamyAWhiteGObholzerRAkkerSTuftonNCaseyRTMaherERParkSMPorteousMDyerRTanTWernigFBradyAFKosicka-SlawinskaMWhitelawBCDorkinsHLallooFBrennanPCarlowJMartinRMitchellALHarrisonRHawkesLNewell-PriceJKelsallAIgbokweRAdlardJSchirwaniSDavidsonRMorrisonPJChungTTBowlesCIzattL.SDHC phaeochromocytoma and paraganglioma: a UK-wide case series.Clin Endocrinol2022;96:499–512
51.
SchiaviFBoedekerCCBauschBPeçzkowskaMGomezCFStrassburgTPawluCBuchtaMSalzmannMHoffmannMMBerlisABrinkICybullaMMuresanMWalterMAForrerFVälimäkiMKaweckiASzutkowskiZSchipperJWalzMKPignyPBautersCWillet-BrozickJEBaysalBEJanuszewiczAEngCOpocherGNeumannHP.Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.JAMA2005;294:2057–63
52.
NiemannSMüllerUEngelhardtDLohseP.Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC.Hum Genet2003;113:92–4
53.
Bernardo-CastiñeiraCValdésNSierraMISáenz-de-Santa-MaríaIBayónGFPerezRFFernándezAFFragaMFAstudilloAMenéndezRFernándezBDel OlmoMSuarezCChiaraMD.SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas.J Clin Endocrinol Metab2018;103:295–305
54.
HanahanDWeinbergRA.Hallmarks of cancer: the next generation.Cell2011;144:646–74
55.
KillianJKMiettinenMWalkerRLWangYZhuYJWaterfallJJNoyesNRetnakumarPYangZSmithWIJrKillianMSLauCCPinedaMWallingJStevensonHSmithCWangZLasotaJKimSYBoikosSAHelmanLJMeltzerPS.Recurrent epimutation of SDHC in gastrointestinal stromal tumors.Sci Transl Med2014;6:268ra177
56.
HallerFMoskalevEAFauczFRBarthelmeßSWiemannSBiegMAssieGBertheratJSchaeferIMOttoCRattenberryEMaherERStröbelPWernerMCarneyJAHartmannAStratakisCAAgaimyA.Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.Endocr Relat Cancer2014;21:567–77
57.
AspuriaPPLuntSYVäremoLVergnesLGozoMBeachJASalumbidesBReueKWiedemeyerWRNielsenJKarlanBYOrsulicS.Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.Cancer Metab2014;2:21
58.
RøslandGVDyrstadSETusubiraDHelwaRTanTZLotsbergMLPettersenIKNBergAKindtCHoelFJacobsenKArasonAJEngelsenASTDitzelHJLønningPEKrakstadCThieryJPLorensJBKnappskogSTronstadKJ.Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.Cancer Metab2019;7:6
59.
KamaiTHigashiSMurakamiSAraiKNamatameTKijimaTAbeHJamiyanTIshidaKShiratakiHYoshidaKI.Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.Cancer Sci2021;112:3375–87
60.
LiJLiangNLongXZhaoJYangJDuXYangTYuanPHuangXZhangJHeXXingJ.SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.Cancer Lett2019;461:44–55
61.
Al KhazalFKangSNelson HolteMChoiDSSinghROrtega-SáenzPLópez-BarneoJMaherLJIII. Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency.FASEB J2021;35:e21227
62.
de MarcoGGarcia-GarciaABRealJTGonzalez-AlbertVBriongos-FigueroLSCobos-SilesMLago-SampedroACorbatonATeresa Martinez-LarradMCarmenaRMartin-EscuderoJCRojo-MartínezGChavesFJ.Respiratory chain polymorphisms and obesity in the Spanish population, a cross-sectional study.BMJ Open2019;9:e027004
63.
BalnisJKorponayTCVincentCESingerDVAdamAPLacomisDLeeCGEliasJASingerHAJaitovichA.IL-13-driven pulmonary emphysema leads to skeletal muscle dysfunction attenuated by endurance exercise.J Appl Physiol2020;128:134–48
64.
BalnisJDrakeLAVincentCEKorponayTCSingerDVLacomisDLeeCGEliasJAJourd’heuilDSingerHAJaitovichA.SDH subunit C regulates muscle oxygen consumption and fatigability in an animal model of pulmonary emphysema.Am J Respir Cell Mol Biol2021;65:259–71
65.
IshiiNTakahashiKTomitaSKeinoTHondaSYoshinoKSuzukiK.A methyl viologen-sensitive mutant of the nematode Caenorhabditis elegans.Mutat Res1990;237:165–71
66.
HosokawaHIshiiNIshidaHIchimoriKNakazawaHSuzukiK.Rapid accumulation of fluorescent material with aging in an oxygen-sensitive mutant mev-1 of Caenorhabditis elegans.Mech Ageing Dev1994;74:161–70
67.
AdachiHFujiwaraYIshiiN.Effects of oxygen on protein carbonyl and aging in Caenorhabditis elegans mutants with long (age-1) and short (mev-1) life spans.J Gerontol A Biol Sci Med Sci1998;53:B240–4
68.
HondaSIshiiNSuzukiKMatsuoM.Oxygen-dependent perturbation of life span and aging rate in the nematode.J Gerontol1993;48:B57–61
69.
TsudaMSugiuraTIshiiTIshiiNAigakiT.A mev-1-like dominant-negative SdhC increases oxidative stress and reduces lifespan in Drosophila.Biochem Biophys Res Commun2007;363:342–6
70.
IshiiTMiyazawaMOnouchiHYasudaKHartmanPSIshiiN.Model animals for the study of oxidative stress from complex II.Biochim Biophys Acta2013;1827:588–97
71.
IshiiTMiyazawaMOnoderaAYasudaKKawabeNKirinashizawaMYoshimuraSMaruyamaNHartmanPSIshiiN.Mitochondrial reactive oxygen species generation by the SDHC V69E mutation causes low birth weight and neonatal growth retardation.Mitochondrion2011;11:155–65
72.
IshiiTMiyazawaMTakanashiYTanigawaMYasudaKOnouchiHKawabeNMitsushitaJHartmanPSIshiiN.Genetically induced oxidative stress in mice causes thrombocytosis, splenomegaly and placental angiodysplasia that leads to recurrent abortion.Redox Biol2014;2:679–85
73.
IshiiTYasudaKMiyazawaMMitsushitaJJohnsonTEHartmanPSIshiiN.Infertility and recurrent miscarriage with complex II deficiency-dependent mitochondrial oxidative stress in animal models.Mech Ageing Dev2016;155:22–35
74.
OnouchiHIshiiTMiyazawaMUchinoYYasudaKHartmanPSKawaiKTsubotaKIshiiN.Mitochondrial superoxide anion overproduction in Tet-mev-1 transgenic mice accelerates age-dependent corneal cell dysfunctions.Invest Ophthalmol Vis Sci2012;53:5780–7
UchinoYKawakitaTIshiiTIshiiNTsubotaK.A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland.Cornea2012;31:S63–7
77.
KluckovaKBezawork-GeletaARohlenaJDongLNeuzilJ.Mitochondrial complex II, a novel target for anti-cancer agents.Biochim Biophys Acta2013;1827:552–64
78.
MinHYJangHJParkKHHyunSYParkSJKimJHSonJKangSSLeeHY.The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II.Cell Death Dis2019;10:810
79.
YanicostasCSoussi-YanicostasN.SDHI fungicide toxicity and associated adverse outcome pathways: what can Zebrafish tell us?Int J Mol Sci2021;22:12362
80.
HorsefieldRYankovskayaVSextonGWhittinghamWShiomiKOmuraSByrneBCecchiniGIwataS.Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction.J Biol Chem2006;281:7309–16
81.
SwettenhamEWittingPKSalvatoreBANeuzilJ.Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system.J Neurochem2005;94:1448–56
82.
KluckovaKStichaMCernyJMracekTDongLDrahotaZGottliebENeuzilJRohlenaJ.Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation.Cell Death Dis2015;6:e1749
83.
HuangLSLümmenPBerryEA.Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors.Biochim Biophys Acta Proteins Proteom2021;1869:140679
